Novel ruthenium gamma linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion (2014)
- Authors:
- USP affiliated authors: SILVA, DENISE DE OLIVEIRA - IQ ; COLQUHOUN, ALISON - ICB ; MIYAKE, JULIANO ANDREOLI - ICB ; BENADIBA, MARCEL - ICB ; RIBEIRO, GEISE - IQ
- Unidades: IQ; ICB
- Subjects: GLIOMA; RUTÊNIO; APOPTOSE; GLIOMA; RATOS; PROLIFERAÇÃO CELULAR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: International Institute of Anticancer Research
- Publisher place: Athens
- Date published: 2014
- Source:
- Título do periódico: Anticancer Research
- ISSN: 0250-7005
- Volume/Número/Paginação/Ano: v. 34, n. 4, p. 1901-1012, 2014
-
ABNT
MIYAKE, Juliano Andreoli; BENADIBA, Marcel; RIBEIRO, Geise; SILVA, Denise de Oliveira; COLQUHOUN, Alison. Novel ruthenium gamma linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion. Anticancer Research, Athens, International Institute of Anticancer Research, v. 34, n. 4, p. 1901-1012, 2014. Disponível em: < http://ar.iiarjournals.org/content/34/4/1901.long >. -
APA
Miyake, J. A., Benadiba, M., Ribeiro, G., Silva, D. de O., & Colquhoun, A. (2014). Novel ruthenium gamma linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion. Anticancer Research, 34( 4), 1901-1012. Recuperado de http://ar.iiarjournals.org/content/34/4/1901.long -
NLM
Miyake JA, Benadiba M, Ribeiro G, Silva D de O, Colquhoun A. Novel ruthenium gamma linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion [Internet]. Anticancer Research. 2014 ; 34( 4): 1901-1012.Available from: http://ar.iiarjournals.org/content/34/4/1901.long -
Vancouver
Miyake JA, Benadiba M, Ribeiro G, Silva D de O, Colquhoun A. Novel ruthenium gamma linolenic acid complex inhibits C6 rat glioma cell proliferation in vitro and in the orthotopic C6 model in vivo after osmotic pump infusion [Internet]. Anticancer Research. 2014 ; 34( 4): 1901-1012.Available from: http://ar.iiarjournals.org/content/34/4/1901.long - Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs)
- Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation
- Inhibition of C6 rat glioma proliferation by ['RU IND. 2''CL''(ibp) IND. 4'] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential
- Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
- Diruthenium(II,III)-non-steroidal anti-inflammatory drug complexes and their effects on tumor-cell proliferation
- Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
- Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line
- Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (nsaid) ibuprofen on the mRNA expression of proteins involved in cell cycle control, Angiogenesis and Invasion in C6 rat glioma cells in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells in vitro
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
